Investors Wish List
Longeveron (LGVN) Shares Surge on Positive Clinical Trial Results
On the US stock charts, shares of Longeveron Inc. (NASDAQ: LGVN) have increased significantly after encouraging clinical trial results were announced. The stock of LGVN increased by 18.17% to $4.07 as of the most recent update. Encouragering Information Delivered at
